Edgewise Therapeutics, Inc. reports

Company location: Boulder, CO
Fiscal year end: 31 December

Edgewise Therapeutics, Inc. has filed 400 SEC EDGAR filings since 26 Sep 2019

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 301-325 of 400 matching filings.

Per page

Current page

EFFECT File 333-264083

EFFECT filing

Filing date: 05 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-264083

424B5

Filing date: 05 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 03 May 2022
Reporting date: 01 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 03 May 2022
Reporting date: 01 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 03 May 2022
Reporting date: 01 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 03 May 2022
Reporting date: 01 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 03 May 2022
Reporting date: 01 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 03 May 2022
Reporting date: 01 May 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

CORRESP

CORRESP filing

Filing date: 03 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-40236

DEFA14A

Filing date: 02 May 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-40236

DEF 14A

Filing date: 02 May 2022
Reporting date: 23 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 08 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-264083

FORM S-3

Filing date: 01 Apr 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date: 28 Feb 2022
Reporting date: 25 Feb 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-262953

FORM S-8

Filing date: 24 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-K File 001-40236

10-K

Filing date: 24 Feb 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date: 24 Feb 2022
Reporting date: 24 Feb 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-92424

SC 13G/A

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92424

SC 13G

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-92424

SC 13G/A filing

Filing date: 14 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92424

SC 13G filing

Filing date: 09 Feb 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

PRIMARY DOCUMENT

Filing date: 25 Jan 2022
Reporting date: 21 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-92424

EDGEWISE THERAPEUTICS, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-92424

EDGEWISE THERAPEUTICS, INC.

Filing date: 13 Jan 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40236

EDGEWISE THERAPEUTICS, INC. 8-K

Filing date: 05 Jan 2022
Reporting date: 05 Jan 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing